✦ LIBER ✦

Second-line erlotinib for non-small-cell lung cancer

✍ Scribed by Vito Lorusso; Saverio Cinieri

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line erlotinib for non-small-cell

✍ Tudor Ciuleanu 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 35 KB

Treatment Monitoring Program for Impleme

✍ Gebbia, Vittorio; Bellavia, Massimo; Banna, Giuseppe Luigi; Russo, Paolo; Ferraù 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 439 KB

PCN67 Erlotinib as Second Line Treatment

✍ Santos, E.A.V.; Buschinelli, C.T.; Ferracini, M.; Pepe, C.; Estanislao, M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

50 IMPLEMENTATION OF ADHERENCE TO ERLOTI

✍ V. Gebbia; G. Bellavia; P. Russo; G.L. Banna; F. Ferraù; P. Tralongo; N. Borsell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

PCN90 Cost-Effectiveness Analysis of Erl

✍ Nguyen, T.T.T.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

90P ERLOTINIB VS CHEMOTHERAPY AS SECOND

✍ Garde, J.; García, J.; Berzosa, M.; Marin, S.; Sangrador, C.; Piera, N.; Hidalgo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB